ABSTRACT
“Subclinical” (mild) thyroid failure is not benign: it tends to progress to overt thyroid failure and it has adverse clinical effects. We believe it should be screened for more aggressively in the general population, and treated with levothyroxine.
Footnotes
↵* The author has indicated receiving grant or research support from Knoll Pharma and Genzyme Corporation, and has acted as a consultant for Knoll Pharma.
- Copyright © 2002 The Cleveland Clinic Foundation. All Rights Reserved.